ArticleMedicine2017

Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs.

Seung Ho Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.